Oura CEO Tom Hale asserts that artificial intelligence has been a foundational element of the company's strategy for years, predating the current widespread AI fervor. Speaking at the Consello Spark Summit, Hale detailed how Oura has consistently integrated AI to enhance its smart ring's capabilities, moving beyond basic data collection to offer predictive health insights.
Related startups
Oura's AI Foundation
Hale explained that the company's approach to AI is deeply embedded in its product development and data analysis. "We've been doing AI for years," Hale stated, emphasizing that the technology is not a new or recent addition to Oura's roadmap. The focus, he elaborated, is on using AI to make predictions about users' health outcomes, rather than merely presenting raw data. This predictive capability aims to help users understand how their behaviors can positively influence their long-term health and potentially reduce healthcare costs.
The full discussion can be found on Bloomberg Technology's YouTube channel.
Advancing Health Metrics with AI
The conversation delved into Oura's ambition to secure FDA clearance for more sophisticated health metrics. Hale mentioned ongoing studies, including a blood pressure profile study involving approximately 300,000 participants, to validate the accuracy of their sensor data against traditional cuff measurements. "We want to make sure that what we do is in line with the FDA as possible," Hale said, indicating a commitment to rigorous scientific and medical validation. This pursuit of FDA clearance signifies Oura's intent to transition its device from a general wellness product to a more medically recognized tool.
